Document is current
Any future updates will be listed below
-
Authors
Zhao, Jingjing
Li, Qiaojuan
Hu, Jia
Yu, Hongwu
Shen, Youmin
Lai, Hongyan
Li, Qin
Zhang, Hena
Li, Yan
Fang, Zhuting
Huang, Shenglin
- License Information
-
More Information
Article History
Received: 7 August 2024
Accepted: 22 October 2024
First Online: 31 October 2024
Declarations
:
: The NSCLC immunotherapy clinical study was approved by the Institutional Review Board of the Fudan University Shanghai Cancer Center (Approval No. 2004216–20-2005).
: Not applicable.
: The authors declare no competing interests.
